And BTX controls the worlds majority:
Scientists in the University of Connecticut’s Technology Incubation Program have identified a novel approach to treating multiple sclerosis (MS) using human embryonic stem cells, offering a promising new therapy for more than 2.3 million people suffering from the debilitating disease.
Today's stem cell news:
The researchers demonstrated that the embryonic stem cell therapy significantly reduced MS disease severity in animal models, and offered better treatment results than stem cells derived from human adult bone marrow.
And yet the stock went down again showing no signs of ending its 4 year horrible trend despite all the partnerships, subsidiaries and positive news. I think we all got in around 10 years too early. We could have followed this the whole time and watched as the price kept getting lower. Now we're stuck.
I agree, I think there is something wrong within the mgmt
people of this company.
This is like the old joke: "The operation was a success but the patient died."
If I had to guess, I would point to A K. as the major problem.